| 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 脉血康胶囊(元) | 202,448,142.79 | 467,209,764.45 | 238,649,523.38 |
| 脉血康片剂(元) | 6,218,309.50 | 14,115,467.57 | 7,515,901.32 |
| 晕痛定胶囊(元) | 28,231,094.17 | 76,194,669.42 | 38,093,863.59 |
| 其他品种(元) | 5,253,744.13 | 18,776,241.60 | 6,785,199.30 |
| 其他业务(元) | - | - | 1,323,605.34 |
| 营业成本(元) | |||
| 脉血康胶囊(元) | 38,053,934.38 | 98,855,383.50 | 56,123,371.92 |
| 脉血康片剂(元) | 2,147,231.59 | 3,097,620.20 | 1,768,041.75 |
| 晕痛定胶囊(元) | 6,913,608.79 | 16,503,684.06 | 7,498,368.07 |
| 其他品种(元) | 2,206,979.11 | 8,348,801.05 | 3,416,234.73 |
| 其他业务(元) | - | - | 1,165,713.68 |
| 毛利(元) | |||
| 脉血康胶囊(元) | 164,394,208.41 | 368,354,380.95 | 182,526,151.46 |
| 脉血康片剂(元) | 4,071,077.91 | 11,017,847.37 | 5,747,859.57 |
| 晕痛定胶囊(元) | 21,317,485.38 | 59,690,985.36 | 30,595,495.52 |
| 其他品种(元) | 3,046,765.02 | 10,427,440.55 | 3,368,964.57 |
| 其他业务(元) | - | - | 157,891.66 |
| 毛利率(%) | |||
| 脉血康胶囊(%) | 81.20 | 78.84 | 76.48 |
| 脉血康片剂(%) | 65.47 | 78.06 | 76.48 |
| 晕痛定胶囊(%) | 75.51 | 78.34 | 80.32 |
| 其他品种(%) | 57.99 | 55.54 | 49.65 |
| 其他业务(%) | - | - | 11.93 |
| 收入构成(%) | |||
| 脉血康胶囊(%) | 83.60 | 81.07 | 81.63 |
| 脉血康片剂(%) | 2.57 | 2.45 | 2.57 |
| 晕痛定胶囊(%) | 11.66 | 13.22 | 13.03 |
| 其他品种(%) | 2.17 | 3.26 | 2.32 |
| 其他业务(%) | - | - | 0.45 |
| 毛利构成(%) | |||
| 脉血康胶囊(%) | 85.25 | 81.95 | 82.07 |
| 脉血康片剂(%) | 2.11 | 2.45 | 2.58 |
| 晕痛定胶囊(%) | 11.06 | 13.28 | 13.76 |
| 其他品种(%) | 1.58 | 2.32 | 1.51 |
| 其他业务(%) | - | - | 0.07 |